Weekly Vaccine Update and Order Reminder 1/28

Weekly Vaccine Update and Order Reminder 1/28

Vaccine Delivery Cadence

• Please place Standard orders in myCAvax on or before the Monday 1/31 5pm deadline. Refer to CDPHs Ordering and Delivery Cadence here.
• Make sure you have submitted your VaccineFinder inventory before you place your order.
• Orders submitted in myCAvax without VaccineFinder inventory information WILL NOT be approved.

Shipping hour validations in myCAvax

myCAvax shipping hours are used for scheduling standard and small order deliveries. Please log into myCAvax and confirm that your shipping hours are correct for each of your active location accounts.

VaxUp Innovation Challenge  

The Los Angeles County Department of Public Health is partnering with the Children’s Hospital Los Angeles Innovation Studio to host the VaxUp Innovation Challenge.  This challenge will be open to any non-profit or for-profit who has a creative and scalable idea to increase COVID-19 vaccination rates among children and teens in the Los Angeles County area. The 3-phased innovation challenge will include 1) a virtual Idea-a-Thon, 2) User Research and Prototyping phase, and 3) Proof of Concept phase with small grants to support the solution.  Interested?  Please email Margeaux Akazawa (makazawa@chla.usc.edu ) to get the latest updates on this exciting Challenge. See flyer or click here for further details.

Stay Up to Date with Your Vaccines

• Fully vaccinated means a person has received their primary series of COVID-19 vaccines.
• Up to date means a person has received all recommended COVID-19 vaccines, including any additional primary or booster dose(s) when eligible.
  • The recommendations will be different depending on your age, your health status, and when you first got vaccinated.
  • Please note that individuals previously infected with COVID-19 can receive vaccine (including a booster dose) once their acute illness has resolved and they have completed isolation.
• A COVID-19 Vaccine Eligibility guide can be found here.
• Recent publications have shown that boosters are a powerful tool to prevent hospitalizations and deaths. We encourage all providers to contact their patients who are 5 years of age and older to strongly recommend that they remain up to date on the COVID-19 vaccination

Updated recommendations for those with COVID-19 vaccinations from outside of the United States

• The January 6, 2022, Update of the CDC COVID-19 Vaccine Clinical Guidance includes additional recommendations for people that have received a vaccine outside of the U.S.
• Persons who received only the first of a WHO-listed COVID-19 vaccine that is not FDA-approved or FDA-authorized do not need to restart a primary vaccination series in the U.S.
• They should receive a single dose of a Pfizer vaccine at least 28 days after receipt of their first dose, after which they are considered fully vaccinated.
• The current WHO list of vaccines for emergency use includes:
  • Pfizer-BioNTech
  • AstraZeneca-Oxford
  • Janssen (J&J)
  • Moderna
  • Sinopharm-BIBP
  • Sinovac-CoronaVac
  • Bharat Biotech International
  • Novavax

Preventing Administration Errors

• Ensure staff are all trained on the vaccines in use and are up to date on the new formulations.
  • Make sure staff know the new gray cap tris-sucrose Pfizer vaccine does not need diluent!
• Double check which product is being administered to the patient (confirm it is approved for their age range)
• See these helpful EZIZ resources:
  • IMM-1411: Vaccine Administration Checklist (eziz.org)
  • IMM-1410: Preventing Administration Errors (eziz.org)

Preventing Administration Errors – Expiration and Beyond Use Dates (BUDs)

• Always double-check expiration and beyond use dates of vaccines before administering
• Expiration Checkers:
  • Vial Expiration Date Lookup | Moderna COVID-19 Vaccine (EUA) (modernatx.com)
  • Janssen COVID-19 Vaccine Expiry Checker (vaxcheck.jnj)
• Pfizer: Check the EUA
  • Pfizer-BioNTech COVID-19 Vaccine for 12 and older – purple cap must dilute (fda.gov)
  • Pfizer-BioNTech CVODI-19 Vaccine for 12 and older – gray cap do not dilute (fda.gov)
  • Pfizer-BioNTech COVID-19 Vaccine 5-11 Years of Age (fda.gov)

Temperature Excursions

• Remember to report temperature excursions in myCAvax.
• Here are helpful links to check vaccine viability:
  • Moderna: Storage & temperature excursion for Moderna COVID-19 vaccine (modernamedinfo.com)
  • Janssen: Janssen COVID-19 Vaccine – Stability – Temperature Excursion (Vials) (janssenmd.com)
  • Pfizer: Use the Digital Assistant: Pfizer-BioNTech COVID-19 Vaccine also known as COMIRNATY (COVID-19 Vaccine, mRNA) | Pfizer Medical Information - US
  • Reminder: Please call medical information for information on gray and orange cap vaccine: 1-800-438-1985

COVID-19 Therapeutics Links

• CDPH COVID-19 antiviral therapeutics page (includes locations with antivirals)
• CDPH monoclonals information page
• CDC therapeutics health advisory
• Therapeutics locations nationwide
• LA County Department of Public Health Therapeutics Page
• For more information, please contact your MHOAC

LAHAN: Addressing Low COVID-19 Vaccination Rates in Children 5-11 Years of Age

A link to LAC DPH Health Advisory: Addressing Low COVID-19 Vaccination Rates in Children 5-11 Years of Age can be found here.

Please subscribe to Los Angeles Health Action Network (LAHAN) for Department of Public Health (DPH) emails priority communications to health care professionals. The website can be found here.

• VaxUp Challenge.pdf